Company

Vector BioPharma AG

Vector BioPharma develops platform technologies for genetic medicine and targeted gene delivery.

About

Founded in 2021 and based in Basel, Switzerland, Vector BioPharma develops platform technologies for genetic medicine. Its capsid shielding technology is designed to support tissue-specific delivery and tunable gene expression. In August 2022, it raised USD 30 million in Series A funding from Versant Ventures.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in